Polaryx Therapeutics PLYX
NASDAQ PLYX
$1.95 +0.08 (+4.28%)
At close: Nov 11, 2026 · 4:00 PM EST

Polaryx Therapeutics (PLYX) Accumulated Expenses (2024 - 2026)

Updated

Polaryx Therapeutics' Accumulated Expenses was $73,000 in Q2 2026, up 62.2% from the prior quarter.

Analysis

Polaryx Therapeutics (PLYX) Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, Accumulated Expenses at Polaryx Therapeutics came in at $23,000, down 73.6% from FY2024.

  • In earlier years, Accumulated Expenses was $87,000 in FY2024.
  • The Q2 2026 figure marks the highest quarterly Accumulated Expenses since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Polaryx Therapeutics 93.21 Mn 68.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 94,000.00
Mar 31, 2026 66,000.00
Dec 31, 2025 44,000.00
Dec 31, 2024 87,000.00
API Access

Polaryx Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PLYX&period=max&api_key=YOUR_API_KEY